Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Feng, Si-Zhou  [Clear All Filters]
2023
Song Y, Gong X-Y, Wei S-N, Li Q-H, Zhang G-J, Wang Y, Wei H, Lin D, Li S-Z, Feng S-Z, et al. [Clinical Analysis of Fusion Gene Positive Patients with Acute Leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(2):352-357.
Xu C-H, Chen X, Zhu G-Q, Yi H-M, Chen S-L, Liu T, Yu Y-T, Zhang Q-H, Jiang E-L, Feng S-Z. Diagnostic performance and clinical impacts of metagenomic sequencing after allogeneic hematopoietic stem cell transplantation. J Microbiol Immunol Infect. 2023.
Liu S, Zhou Z, Zhai W-J, Song X-N, Li Q, Jiang E-L, Feng S-Z, Sun J-L. [The Relationship between Occurrence of aGVHD in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation and Immune Cell Components in Graft]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(2):539-545.
2019
Cao Y-G, He Y, Zhang S-D, Liu Z-X, Zhai W-H, Ma Q-L, Pang A-M, Wei J-L, Yang D-L, Huang Y, et al. Conditioning regimen of 5-day decitabine administration for allogeneic stem cell transplantation in patients with myelodysplastic syndrome and myeloproliterative neoplasms. Biol Blood Marrow Transplant. 2019.
2013
Yan F-H, Wang M, Huang Y, Jiang E-L, Ma Q-L, Wei J-L, Pang A-M, Zhang R-L, Feng S-Z, Han M-Z. [Analyses of risk factors for intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2013;34(12):1020-3.